Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Immunology. 2019 Aug;157(4):281-282. doi: 10.1111/imm.13092.
The study of cellular and molecular immunology is almost completely dependent on monoclonal antibody technology. Despite the relatively long history of monoclonal antibodies, there is still huge potential for developing novel and transformative uses for this technology. In this issue of Immunology, we present two such papers, one focussing on anti-complement (C5) antibodies, the other on anti-CD6-specific antibodies. Both manuscripts describe novel ways that monoclonal antibodies may be used for scientific and potentially for therapeutic benefit.
细胞和分子免疫学的研究几乎完全依赖于单克隆抗体技术。尽管单克隆抗体的历史相对较长,但这项技术仍有很大的潜力可以开发出新的、具有变革性的用途。在本期《免疫学》中,我们呈现了两篇这样的论文,一篇聚焦于抗补体(C5)抗体,另一篇聚焦于抗 CD6 特异性抗体。这两篇手稿都描述了单克隆抗体可能被用于科学研究,甚至可能具有治疗作用的新方法。